Koru Medical Systems Inc has 6 Schedule 13D or 13G filings on record since 2026-01-21. 4 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Horton Capital Partners, LLC | 12.62% | 5,062,498 | SCHEDULE 13D/A, 2026-02-13 | 2026-02-13 |
| Topline Capital Management, LLC | 8.5% | 3,941,014 | SCHEDULE 13G/A, 2026-02-13 | 2025-12-31 |
| Mathew P. Arens | 8.27% | 3,831,475 | SCHEDULE 13G/A, 2026-02-17 | 2025-12-31 |
| BlackRock, Inc. | 5.6% | 2,575,761 | SCHEDULE 13G, 2026-07-29 | 2026-06-30 |
Purpose of Transaction (Item 4)
Horton Capital Partners, LLC
The Reporting Persons acquired the shares of Common Stock for investment purposes. The purpose of this Amendment No. 12 is to disclose changes in the beneficial ownership of the shares of Common Stock held by the Reporting Persons including: (i) the issuance of shares of Common Stock to HCPF in consideration for Mr. Manko's service as a director of the Issuer (the "Director Shares"); (ii) that HCPF transferred shares of Common Stock to certain of its limited partners; and (iii) that HCP transferred shares of Common Stock to certain of its members, including Mr. Manko. On January 10, 2024, Horton Freedom, L.P., ("Horton Freedom") in accordance with its terms, transferred 453,231 shares of Common Stock to certain of its limited partners, representing the remaining pro-rata in-kind distribution in respect of such limited partners' interests in Horton Freedom. As a result, as of January 10, 2024, Horton Freedom held 0 shares of Common Stock. On February 15, 2024, HCPF, in accordance with its terms, transferred 27,700 shares of Common Stock to a limited partner, representing a pro-rata in-kind distribution in respect of such limited partner's interest in HCPF. On March 31, 2024, 6,329 Director Shares were issued to HCPF; on June 30, 2024, 5,545 Director Shares were issued to HCPF; on September 30, 2024, 5,454 Director Shares were issued to HCPF; and on December 31, 2024, 3,937 Director Shares were issued to HCPF. On July 24, 2024, HCPF, in accordance with its terms, …The first part of Item 4 of the SCHEDULE 13D/A filed 2026-02-13; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-01-21 | BlackRock, Inc. | 5.1% | SCHEDULE 13G |
| 2026-02-13 | Horton Capital Partners, LLC | 12.62% | SCHEDULE 13D/A |
| 2026-02-13 | Topline Capital Management, LLC | 8.5% | SCHEDULE 13G/A |
| 2026-02-17 | Mathew P. Arens | 8.27% | SCHEDULE 13G/A |
| 2026-04-27 | BlackRock, Inc. | 4.9% | SCHEDULE 13G/A |
| 2026-07-29 | BlackRock, Inc. | 5.6% | SCHEDULE 13G |
Tools for this story
Each opens in a new tab, filled in for Koru Medical Systems Inc. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.